Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak

Trends Immunol. 2020 Oct;41(10):849-851. doi: 10.1016/j.it.2020.06.011. Epub 2020 Jun 29.

Authors

C Jessica E Metcalf¹, Cecile Viboud², David J Spiro², Bryan T Grenfell³

Affiliations

¹ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA. Electronic address: cmetcalf@princeton.edu.
² Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
³ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

No abstract available

MeSH terms

Antibodies, Viral / blood*
Betacoronavirus / pathogenicity*
COVID-19
Computer Simulation
Coronavirus Infections / diagnosis
Coronavirus Infections / epidemiology*
Coronavirus Infections / transmission*
Coronavirus Infections / virology
Humans
Immune Sera / chemistry
Models, Immunological*
Pandemics*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / transmission*
Pneumonia, Viral / virology
Public Health
SARS-CoV-2
Seroepidemiologic Studies
United States / epidemiology

Substances

Antibodies, Viral
Immune Sera